Letter: substantial under-diagnosis of NAFLD - more efforts are needed globally
- PMID: 33085985
- DOI: 10.1111/apt.16110
Letter: substantial under-diagnosis of NAFLD - more efforts are needed globally
Comment on
-
Patterns and predictors of mortality and disease progression among patients with non-alcoholic fatty liver disease.Aliment Pharmacol Ther. 2020 Oct;52(7):1185-1194. doi: 10.1111/apt.16016. Epub 2020 Aug 17. Aliment Pharmacol Ther. 2020. PMID: 33016540
References
REFERENCES
-
- Canbay A, Kachru N, Haas JS, Sowa JP, Meise D, Ozbay AB. Patterns and predictors of mortality and disease progression among patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2020;52:1185-1194. https://doi.org/10.1111/apt.16016
-
- Andersohn F, Walker J. Characteristics and external validity of the German Health Risk Institute (HRI) Database. Pharmacoepidemiol Drug Saf. 2016;25(1):106-109. https://doi.org/10.1002/pds.3895
-
- Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84. https://doi.org/10.1002/hep.28431
-
- Zou B, Yeo YH, Nguyen VH, Cheung R, Ingelsson E, Nguyen MH. Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016. J Intern Med. 2020;288(1):139-151. https://doi.org/10.1111/joim.13069
-
- Le MH, Yeo YH, Cheung R, Wong VWS, Nguyen MH. Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011-2016. J Intern Med. 2020;287(6):711-722. https://doi.org/10.1111/joim.13035
Publication types
MeSH terms
LinkOut - more resources
Medical